The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Helminth infections associated with multiple sclerosis induce regulatory B cells
Abstract
Objective: To assess the importance of B‐cell control during parasite infections in multiple sclerosis (MS) patients. Methods: Peripheral blood CD19+ B cells from 12 helminth‐infected MS patients, 12 MS patients without infection, 10 patients infected with Trypanosoma cruzi, 8 subjects infected with Paracoccidioides brasiliensis, and 12 healthy control subjects were purified using magnetic cell sorting. Interleukin (IL)‐4, IL‐6, IL‐10, tumor necrosis factor‐α, lymphotoxin, transforming growth factor‐β, brain‐derived neurotrophic factor, and nerve growth factor secretion were evaluated after stimulation with CDw32 L cells and CD40 antibody using enzyme‐linked immunosorbent assays. The production of anti–myelin oligodendrocyte glycoprotein IgG and IgM antibodies was evaluated by enzyme‐linked immunosorbent spot assays. Cell phenotype was assessed by flow cytometry. Results: Helminth infections in MS patients created a B‐cell population producing high levels of IL‐10, dampening harmful immune responses through a mechanism mediated, at least in part, by the ICOS‐B7RP‐1 pathway. The IL‐10–producing B‐cell phenotype detected expressed high levels of CD1d and was similar to the one observed in mature naive B2 cells (namely, CD11b−, CD5−, CD27−, and IgD+). Moreover, B cells isolated from helminth‐infected MS patients also produced greater amounts of brain‐derived neurotrophic factor and nerve growth factor compared with those of normal subjects, T. cruzi–infected subjects, P. brasiliensis–infected subjects, or uninfected MS patients, raising the possibility that these cells may exert a neuroprotective effect on the central nervous system. Interpretation: Increased production of B‐cell–derived IL‐10 and of neurotrophic factors are part of the parasite's regulation of host immunity and can alter the course of MS, potentially explaining environmental‐related MS suppression observed in areas with low disease prevalence. Ann Neurol 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A. (1999) · Nature · doi:10.1038/16717 · Cited by 1,482
Gene silencing in mammals by small interfering RNAs
McManus, M. T., & Sharp, P. A. (2002) · Nature Reviews Genetics · doi:10.1038/nrg908 · Cited by 1,399
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
Kerschensteiner, M., Gallmeier, E., Behrens, L., Leal, V. V., Misgeld, T., Klinkert, W. E. F., Kolbeck, R., Hoppe, E., Oropeza-Wekerle, R.-L., Bartke, I., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.865 · Cited by 1,019
Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S., & Bhan, A. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00274-1 · Cited by 978
Going both ways: Immune regulation via CD1d-dependent NKT cells
Godfrey, D. I., & Kronenberg, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423594 · Cited by 877
Prevention of Arthritis by Interleukin 10–producing B Cells
Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 860
Cited by
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
“, 2007) (Correale et al., 2008).”
ResultImmune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Diversity and dialogue in immunity to helminths
Allen, J. E., & Maizels, R. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri2992 · Cited by 831
Regulation of the host immune system by helminth parasites
Maizels, R. M., & McSorley, H. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.007 · Cited by 529
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
Bar‐Or, A., Fawaz, L., Fan, B., Darlington, P. J., Rieger, A., Ghorayeb, C., Calabresi, P. A., Waubant, E., Hauser, S. L., Zhang, J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21939 · Cited by 521
Antibody-independent functions of B cells: a focus on cytokines
Shen, P., & Fillatreau, S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3857 · Cited by 508
Helminth infections and host immune regulation
McSorley, H. J., & Maizels, R. M. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05040-11 · Cited by 499
Human regulatory B cells in health and disease: therapeutic potential
Mauri, C., & Menon, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci85113 · Cited by 418
Hygiene Hypothesis and Autoimmune Diseases
Rook, G. A. W. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8285-8 · Cited by 405
Reassessing B cell contributions in multiple sclerosis
Li, R., Patterson, K. R., & Bar-Or, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0135-x · Cited by 401
Immunosuppressive Mechanisms of Regulatory B Cells
Catalán, D., Mansilla, M. A., Ferrier, A., Soto, L., Oleinika, K., Aguillón, J. C., & Aravena, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.611795 · Cited by 399
Matsushita, T., Horikawa, M., Iwata, Y., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001307 · Cited by 394
Amu, S., Saunders, S. P., Kronenberg, M., Mangan, N. E., Atzberger, A., & Fallon, P. G. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.01.018 · Cited by 368
Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
Bar-Or, A., Pachner, A., Menguy-Vacheron, F., Kaplan, J., & Wiendl, H. (2014) · Drugs · doi:10.1007/s40265-014-0212-x · Cited by 356
Immunomodulation by helminth parasites: Defining mechanisms and mediators
McSorley, H. J., Hewitson, J. P., & Maizels, R. M. (2013) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.11.011 · Cited by 319
The expanding family of regulatory B cells
Mauri, C., & Menon, M. (2015) · International Immunology · doi:10.1093/intimm/dxv038 · Cited by 297
Carter, N. A., Rosser, E. C., & Mauri, C. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3736 · Cited by 284
Role of B Cells in Multiple Sclerosis and Related Disorders
Comi, G., Bar‐Or, A., Lassmann, H., Uccelli, A., Hartung, H., Montalban, X., Sørensen, P. S., Hohlfeld, R., Hauser, S. L., & Expert Panel of the 27th Annual Meeting of the European Charcot Foundation (2021) · Annals of Neurology · doi:10.1002/ana.25927 · Cited by 283
Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 study
Fleming, J., Isaak, A., Lee, J., Luzzio, C., Carrithers, M., Cook, T., Field, A., Boland, J., & Fabry, Z. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511398054 · Cited by 260
P2Y12 expression and function in alternatively activated human microglia
Moore, C. S., Ase, A. R., Kinsara, A., Rao, V. T. S., Michell-Robinson, M., Leong, S. Y., Butovsky, O., Ludwin, S. K., Séguéla, P., Bar-Or, A., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000080 · Cited by 212
The impact of parasite infections on the course of multiple sclerosis
Correale, J., & Farez, M. F. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.01.002 · Cited by 212
Self-citationTo B or not to B: B cells and the Th2-type immune response to helminths
Harris, N., & Gause, W. C. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.11.005 · Cited by 166
Regulation of immunity and allergy by helminth parasites
Maizels, R. M. (2020) · Allergy · doi:10.1111/all.13944 · Cited by 162
Regulatory B-cell induction by helminths: implications for allergic disease
Hussaarts, L., van der Vlugt, L. E. P. M., Yazdanbakhsh, M., & Smits, H. H. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.012 · Cited by 131
Chronic Helminth Infections Protect Against Allergic Diseases by Active Regulatory Processes
Smits, H. H., Everts, B., Hartgers, F. C., & Yazdanbakhsh, M. (2010) · Current Allergy and Asthma Reports · doi:10.1007/s11882-009-0085-3 · Cited by 130
Lampropoulou, V., Calderon‐Gomez, E., Roch, T., Neves, P., Shen, P., Stervbo, U., Boudinot, P., Anderton, S. M., & Fillatreau, S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00855.x · Cited by 130
Parasitic helminth infections and the control of human allergic and autoimmune disorders
Maizels, R. M. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.024 · Cited by 121
Microbiota, immunoregulatory old friends and psychiatric disorders
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_15 · Cited by 117
Haeberlein, S., Obieglo, K., Ozir-Fazalalikhan, A., Chayé, M. A. M., Veninga, H., van der Vlugt, L. E. P. M., Voskamp, A., Boon, L., den Haan, J. M. M., Westerhof, L. B., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006539 · Cited by 96
Williamson, L. L., McKenney, E. A., Holzknecht, Z. E., Belliveau, C., Rawls, J. F., Poulton, S., Parker, W., & Bilbo, S. D. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.006 · Cited by 84
Blount, D., Hooi, D., Feary, J., Venn, A., Telford, G., Brown, A., Britton, J., & Pritchard, D. (2009) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.09-0237 · Cited by 69
Helminthic therapy: improving mucosal barrier function
Wolff, M. J., Broadhurst, M. J., & Loke, P. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.02.008 · Cited by 59
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity
Ben-Ami Shor, D., Harel, M., Eliakim, R., & Shoenfeld, Y. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8352-9 · Cited by 57
Helminth infection in populations undergoing epidemiological transition: a friend or foe?
Wiria, A. E., Djuardi, Y., Supali, T., Sartono, E., & Yazdanbakhsh, M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0358-0 · Cited by 54
Helminth-Derived Immunomodulatory Molecules
Adisakwattana, P., Saunders, S. P., Nel, H. J., & Fallon, P. G. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-1601-3_8 · Cited by 24
Metadata
- Authors
- Correale, J., Farez, M., & Razzitte, G.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-07-24
- Volume
- 64
- Issue
- 2
- Pages
- 187-199
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2048362681
- Cited by
- 311
- References
- 44
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.